Concepedia

Žhong Yuan

ŽY

Statistics

Publications

67

Citations

4K

H-Index

33

Active since

1995

Affiliations

Janssen (United States)(Current)

Case Western Reserve University

Johnson & Johnson (United States)

University Hospitals of Cleveland

Clinical Research Institute

Žhong Yuan is an author at Janssen (United States) specializing in medicine, pharmacotherapy, and cardiovascular disease.

ORCID

Publications per year

1995–2024

67

Publications

67

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

Scott M. Grundy, Gloria Lena Vega, Žhong Yuan et al. · The American Journal of Cardiology · 2005 · 310 citations

, , +14

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

Milan Radovich, Guanglong Jiang, Bradley A. Hancock et al. · JAMA Oncology · 2020 · 302 citations · Full text

, , +16

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

Christie M. Ballantyne, Nicola Abate, Žhong Yuan et al. · American Heart Journal · 2005 · 240 citations

, , +14

Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor

Jacob A. Udell, Žhong Yuan, Toni Rush et al. · Circulation · 2017 · 229 citations · Full text

, , +17

Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors

Christopher L. Taylor, Žhong Yuan, Warren R. Selman et al. · Journal of neurosurgery · 1995 · 208 citations

, , +16

1–5 of 67